SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001572407-14-000005
Filing Date
2014-05-15
Accepted
2014-05-15 16:08:35
Documents
1
Period of Report
2014-04-22

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3178
  Complete submission text file 0001572407-14-000005.txt   4813
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
RXi Pharmaceuticals Corp (Issuer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1 KENDALL SQUARE BUILDING 200 SUITE 2203 CAMBRIDGE MA 02139
Business Address 1 KENDALL SQUARE BUILDING 200 SUITE 2203 CAMBRIDGE MA 02139 720-936-6628
Advanced RNA Technologies, LLC (Reporting) CIK: 0001572407 (see all company filings)

State of Incorp.: CO | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36304 | Film No.: 14847113